RR

Ruchikumari Rakeshbhai Katiyar

Active Director Director DIN 09420091
DIN 09420091 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ruchikumari Rakeshbhai Katiyar

Data last updated:

Ruchikumari Rakeshbhai Katiyar is a Director at Methealth Formulations Private Limited (since 2021). The company operates in Pharma.

DIN 09420091
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20212021Active

Board colleagues of Ruchikumari Rakeshbhai Katiyar

Directorship timeline

Open interactive timeline →
Methealth Formulations Private Limited
Premium access

Shareholding and investment profile for Ruchikumari Rakeshbhai Katiyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruchikumari Rakeshbhai Katiyar

Ruchikumari Rakeshbhai Katiyar currently holds 1 directorship: Methealth Formulations Private Limited (Director, since 01 Dec 2021).

Ruchikumari Rakeshbhai Katiyar was first appointed on 01 Dec 2021 as Director at Methealth Formulations Private Limited.

The current boards of Ruchikumari Rakeshbhai Katiyar's companies include Ankit Katiyar (Methealth Formulations Private Limited), Namrata Patel (Methealth Formulations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available